{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:10:54Z","timestamp":1761894654237},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,1,14]],"date-time":"2008-01-14T00:00:00Z","timestamp":1200268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2008,1,14]],"date-time":"2008-01-14T00:00:00Z","timestamp":1200268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Primary breast cancer involving four or more axillary lymph nodes carries a poor prognosis. We hypothesized that use of an immunohistochemical biomarker scoring system could allow for identification of variable risk subgroups.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Patients with four or more positive axillary nodes were identified from a clinically annotated tissue microarray of formalin-fixed paraffin-embedded primary breast cancers and randomized into a 'test set' and a 'validation set'. A prospectively defined prognostic scoring model was developed in the test set and was further assessed in the validation set combining expression for eight biomarkers by immunohistochemistry, including estrogen receptor, human epidermal growth factor receptors 1 and 2, carbonic anhydrase IX, cytokeratin 5\/6, progesterone receptor, p53 and Ki-67. Survival outcomes were analyzed by the Kaplan\u2013Meier method, log rank tests and Cox proportional-hazards models.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>A total of 313 eligible patients were identified in the test set for whom 10-year relapse-free survival was 38.3% (SEM 2.9%), with complete immunohistochemical data available for 227. Tumor size, percentage of positive axillary nodes and expression status for the progesterone receptor, Ki-67 and carbonic anhydrase IX demonstrated independent prognostic significance with respect to relapse-free survival. Our combined biomarker scoring system defined three subgroups in the test set with mean 10-year relapse-free survivals of 75.4% (SEM 7.0%), 35.3% (SEM 4.1%) and 19.3% (SEM 7.0%). In the validation set, differences in relapse-free survival for these subgroups remained statistically significant but less marked.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>Biomarkers assessed here carry independent prognostic value for breast cancer with four or more positive axillary nodes and identified clinically relevant prognostic subgroups. This approach requires refinement and validation of methodology.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/bcr1847","type":"journal-article","created":{"date-parts":[[2008,1,15]],"date-time":"2008-01-15T07:14:50Z","timestamp":1200381290000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study"],"prefix":"10.1186","volume":"10","author":[{"given":"Simon J","family":"Crabb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris D","family":"Bajdik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline H","family":"Speers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagen","family":"Kennecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G","family":"Huntsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen A","family":"Gelmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,1,14]]},"reference":[{"key":"1811_CR1","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ejca.2005.11.021","volume":"42","author":"E Espinosa","year":"2006","unstructured":"Espinosa E, Redondo A, Vara JA, Zamora P, Casado E, Cejas P, Baron MG: High-throughput techniques in breast cancer: a clinical perspective. Eur J Cancer. 2006, 42: 598-607. 10.1016\/j.ejca.2005.11.021.","journal-title":"Eur J Cancer"},{"key":"1811_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1136\/jcp.2005.028324","volume":"59","author":"JS Reis-Filho","year":"2006","unstructured":"Reis-Filho JS, Westbury C, Pierga JY: The impact of expression profiling on prognostic and predictive testing in breast cancer. J Clin Pathol. 2006, 59: 225-231. 10.1136\/jcp.2005.028324.","journal-title":"J Clin Pathol"},{"key":"1811_CR3","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1200\/JCO.2002.02.026","volume":"20","author":"SE Singletary","year":"2002","unstructured":"Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark G, Edge SB, Hayes DF, Hughes LL, Hutter RV, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver DL, Wieand HS, Greene FL: Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002, 20: 3628-3636. 10.1200\/JCO.2002.02.026.","journal-title":"J Clin Oncol"},{"key":"1811_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H","volume":"63","author":"CL Carter","year":"1989","unstructured":"Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989, 63: 181-187. 10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H.","journal-title":"Cancer"},{"key":"1811_CR5","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/annonc\/mdi326","volume":"16","author":"A Goldhirsch","year":"2005","unstructured":"Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ: Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol. 2005, 16: 1569-1583. 10.1093\/annonc\/mdi326.","journal-title":"Ann Oncol"},{"key":"1811_CR6","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/jnci\/93.13.979","volume":"93","author":"P Eifel","year":"2001","unstructured":"Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ, Deshler A, Fulton S, Hendricks CB, Kemeny M, Kornblith AB, Louis TA, Markman M, Mayer R, Roter D: National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1\u20133, 2000. J Natl Cancer Inst. 2001, 93: 979-989. 10.1093\/jnci\/93.13.979.","journal-title":"J Natl Cancer Inst"},{"key":"1811_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/ijc.21004","volume":"116","author":"DM Abd El-Rehim","year":"2005","unstructured":"Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JF, Macmillan D, Blamey RW, Ellis IO: High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer. 2005, 116: 340-350. 10.1002\/ijc.21004.","journal-title":"Int J Cancer"},{"key":"1811_CR8","doi-asserted-by":"publisher","first-page":"6143","DOI":"10.1158\/1078-0432.CCR-04-0429","volume":"10","author":"NA Makretsov","year":"2004","unstructured":"Makretsov NA, Huntsman DG, Nielsen TO, Yorida E, Peacock M, Cheang MCU, Dunn SE, Hayes M, van de Rijn M, Bajdik C, Gilks CB: Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma. Clin Cancer Res. 2004, 10: 6143-6151. 10.1158\/1078-0432.CCR-04-0429.","journal-title":"Clin Cancer Res"},{"key":"1811_CR9","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1158\/1078-0432.CCR-06-1383","volume":"12","author":"M Dolled-Filhart","year":"2006","unstructured":"Dolled-Filhart M, Ryden L, Cregger M, Jirstrom K, Harigopal M, Camp RL, Rimm DL: Classification of breast cancer using genetic algorithms and tissue microarrays. Clin Cancer Res. 2006, 12: 6459-6468. 10.1158\/1078-0432.CCR-06-1383.","journal-title":"Clin Cancer Res"},{"key":"1811_CR10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1158\/0008-5472.767.65.3","volume":"65","author":"J Jacquemier","year":"2005","unstructured":"Jacquemier J, Ginestier C, Rougemont J, Bardou VJ, Charafe-Jauffret E, Geneix J, Adelaide J, Koki A, Houvenaeghel G, Hassoun J, Maraninchi D, Viens P, Birnbaum D, Bertucci F: Protein expression profiling identifies subclasses of breast cancer and predicts prognosis. Cancer Res. 2005, 65: 767-779.","journal-title":"Cancer Res"},{"key":"1811_CR11","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D: Molecular portraits of human breast tumours. Nature. 2000, 406: 747-752. 10.1038\/35021093.","journal-title":"Nature"},{"key":"1811_CR12","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001, 98: 10869-10874. 10.1073\/pnas.191367098.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1811_CR13","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1200\/JCO.2006.07.1522","volume":"25","author":"S Loi","year":"2007","unstructured":"Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt AM, Gillet C, Ellis P, Harris A, Bergh J, Foekens JA, Klijn JG, Larsimont D, Buyse M, Bontempi G, Delorenzi M, Piccart MJ, Sotiriou C: Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol. 2007, 25: 1239-1246. 10.1200\/JCO.2006.07.1522.","journal-title":"J Clin Oncol"},{"key":"1811_CR14","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/jnci\/djj329","volume":"98","author":"M Buyse","year":"2006","unstructured":"Buyse M, Loi S, van't Veer L, Viale G, Delorenzi M, Glas AM, d'Assignies MS, Bergh J, Lidereau R, Ellis P, Harris A, Bogaerts J, Therasse P, Floore A, Amakrane M, Piette F, Rutgers E, Sotiriou C, Cardoso F, Piccart MJ: Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst. 2006, 98: 1183-1192.","journal-title":"J Natl Cancer Inst"},{"key":"1811_CR15","doi-asserted-by":"publisher","first-page":"8623","DOI":"10.1158\/1078-0432.CCR-05-0735","volume":"11","author":"MA Cobleigh","year":"2005","unstructured":"Cobleigh MA, Tabesh B, Bitterman P, Baker J, Cronin M, Liu M-L, Borchik R, Mosquera J-M, Walker MG, Shak S: Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes. Clin Cancer Res. 2005, 11: 8623-8631. 10.1158\/1078-0432.CCR-05-0735.","journal-title":"Clin Cancer Res"},{"key":"1811_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1056\/NEJMoa052933","volume":"355","author":"C Fan","year":"2006","unstructured":"Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DSA, Nobel AB, van't Veer LJ, Perou CM: Concordance among gene-expression-based predictors for breast cancer. N Engl J Med. 2006, 355: 560-569. 10.1056\/NEJMoa052933.","journal-title":"N Engl J Med"},{"key":"1811_CR17","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004, 351: 2817-2826. 10.1056\/NEJMoa041588.","journal-title":"N Engl J Med"},{"key":"1811_CR18","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1056\/NEJMoa021967","volume":"347","author":"MJ van de Vijver","year":"2002","unstructured":"van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002, 347: 1999-2009. 10.1056\/NEJMoa021967.","journal-title":"N Engl J Med"},{"key":"1811_CR19","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ van't Veer","year":"2002","unstructured":"van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH: Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002, 415: 530-536. 10.1038\/415530a.","journal-title":"Nature"},{"key":"1811_CR20","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/ncponc0591","volume":"3","author":"J Bogaerts","year":"2006","unstructured":"Bogaerts J, Cardoso F, Buyse M, Braga S, Loi S, Harrison JA, Bines J, Mook S, Decker N, Ravdin P, Therasse P, Rutgers E, van't Veer LJ, Piccart M: Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial. Nat Clin Pract Oncol. 2006, 3: 540-551. 10.1038\/ncponc0591.","journal-title":"Nat Clin Pract Oncol"},{"key":"1811_CR21","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1200\/JCO.2005.04.7985","volume":"24","author":"S Paik","year":"2006","unstructured":"Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, Costantino JP, Geyer CE, Wickerham DL, Wolmark N: Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol. 2006, 24: 3726-3734. 10.1200\/JCO.2005.04.7985.","journal-title":"J Clin Oncol"},{"key":"1811_CR22","volume-title":"Breast Cancer Res Treat","author":"AB Rajput","year":"2007","unstructured":"Rajput AB, Turbin DA, Cheang MC, Voduc DK, Leung S, Gelmon KA, Gilks CB, Huntsman DG: Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases. Breast Cancer Res Treat. 2007, doi:10.1007\/s10549-007-9546-3"},{"key":"1811_CR23","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1200\/JCO.2001.19.16.3660","volume":"19","author":"SK Chia","year":"2001","unstructured":"Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J, Gatter KC, Ratcliffe P, Harris AL: Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol. 2001, 19: 3660-3668.","journal-title":"J Clin Oncol"},{"key":"1811_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/modpathol.3800272","volume":"18","author":"TL Ng","year":"2005","unstructured":"Ng TL, Gown AM, Barry TS, Cheang MC, Chan AK, Turbin DA, Hsu FD, West RB, Nielsen TO: Nuclear \u03b2-catenin in mesenchymal tumors. Mod Pathol. 2005, 18: 68-74. 10.1038\/modpathol.3800272.","journal-title":"Mod Pathol"},{"unstructured":"Genetic Pathology Evaluation Centre TMA Viewer. (username fourplus; password fourplus), [http:\/\/www.gpecimage.ubc.ca\/tma\/web\/viewer.php]","key":"1811_CR25"},{"key":"1811_CR26","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1200\/JCO.2005.06.178","volume":"23","author":"IA Olivotto","year":"2005","unstructured":"Olivotto IA, Bajdik CD, Ravdin PM, Speers CH, Coldman AJ, Norris BD, Davis GJ, Chia SK, Gelmon KA: Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol. 2005, 23: 2716-2725. 10.1200\/JCO.2005.06.178.","journal-title":"J Clin Oncol"},{"unstructured":"Adjuvant! Online. [http:\/\/www.adjuvantonline.com\/index.jsp]","key":"1811_CR27"},{"key":"1811_CR28","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1200\/JCO.2001.19.4.980","volume":"19","author":"PM Ravdin","year":"2001","unstructured":"Ravdin PM, Siminoff LA, Davis GJ, Mercer MB, Hewlett J, Gerson N, Parker HL: Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol. 2001, 19: 980-991.","journal-title":"J Clin Oncol"},{"key":"1811_CR29","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1002\/cncr.20969","volume":"103","author":"PT Truong","year":"2005","unstructured":"Truong PT, Berthelet E, Lee J, Kader HA, Olivotto IA: The prognostic significance of the percentage of positive\/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer. 2005, 103: 2006-2014. 10.1002\/cncr.20969.","journal-title":"Cancer"},{"key":"1811_CR30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/sj.bjc.6603530","volume":"96","author":"SA Hussain","year":"2007","unstructured":"Hussain SA, Ganesan R, Reynolds G, Gross L, Stevens A, Pastorek J, Murray PG, Perunovic B, Anwar MS, Billingham L, James ND, Spooner D, Poole CJ, Rea DW, Palmer DH: Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br J Cancer. 2007, 96: 104-109. 10.1038\/sj.bjc.6603530.","journal-title":"Br J Cancer"},{"key":"1811_CR31","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1158\/1078-0432.CCR-05-2719","volume":"12","author":"GM Callagy","year":"2006","unstructured":"Callagy GM, Pharoah PD, Pinder SE, Hsu FD, Nielsen TO, Ragaz J, Ellis IO, Huntsman D, Caldas C: Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index. Clin Cancer Res. 2006, 12: 2468-2475. 10.1158\/1078-0432.CCR-05-2719.","journal-title":"Clin Cancer Res"},{"key":"1811_CR32","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/sj.onc.1209985","volume":"26","author":"SF Chin","year":"2007","unstructured":"Chin SF, Wang Y, Thorne NP, Teschendorff AE, Pinder SE, Vias M, Naderi A, Roberts I, Barbosa-Morais NL, Garcia MJ, Iyer NG, Kranjac T, Robertson JF, Aparicio S, Tavare S, Ellis I, Brenton JD, Caldas C: Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers. Oncogene. 2007, 26: 1959-1970. 10.1038\/sj.onc.1209985.","journal-title":"Oncogene"},{"key":"1811_CR33","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/path.1694","volume":"205","author":"G Callagy","year":"2005","unstructured":"Callagy G, Pharoah P, Chin SF, Sangan T, Daigo Y, Jackson L, Caldas C: Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays. J Pathol. 2005, 205: 388-396. 10.1002\/path.1694.","journal-title":"J Pathol"},{"key":"1811_CR34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1471-2164-7-96","volume":"7","author":"Z Hu","year":"2006","unstructured":"Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, Nobel A, Parker J, Ewend MG, Sawyer LR, Wu J, Liu Y, Nanda R, Tretiakova M, Ruiz Orrico A, Dreher D, Palazzo JP, Perreard L, Nelson E, Mone M, Hansen H, Mullins M, Quackenbush JF, Ellis MJ, Olopade OI, Bernard PS, et al: The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics. 2006, 7: 96-10.1186\/1471-2164-7-96. doi:10.1186\/1471-2164-1187-1196","journal-title":"BMC Genomics"},{"key":"1811_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5","volume":"19","author":"DG Altman","year":"2000","unstructured":"Altman DG, Royston P: What do we mean by validating a prognostic model?. Stat Med. 2000, 19: 453-473. 10.1002\/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5.","journal-title":"Stat Med"},{"key":"1811_CR36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1200\/JCO.1997.15.1.216","volume":"15","author":"A Olivotto","year":"1997","unstructured":"Olivotto A, Coldman AJ, Hislop TG, Trevisan CH, Kula J, Goel V, Sawka C: Compliance with practice guidelines for node-negative breast cancer. J Clin Oncol. 1997, 15: 216-222.","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr1847.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr1847\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr1847.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T11:06:40Z","timestamp":1728385600000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr1847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,2]]}},"alternative-id":["1811"],"URL":"https:\/\/doi.org\/10.1186\/bcr1847","relation":{},"ISSN":["1465-542X"],"issn-type":[{"type":"electronic","value":"1465-542X"}],"subject":[],"published":{"date-parts":[[2008,1,14]]},"assertion":[{"value":"23 August 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R6"}}